Banks - Regional
Compare Stocks
4 / 10Stock Comparison
FXNC vs MNSB vs NKSH vs CARE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
FXNC vs MNSB vs NKSH vs CARE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $253M | $176M | $239M | $583M |
| Revenue (TTM) | $112M | $136M | $85M | $255M |
| Net Income (TTM) | $18M | $16M | $16M | $31M |
| Gross Margin | 74.0% | 54.4% | 65.1% | 61.7% |
| Operating Margin | 19.6% | 14.0% | 22.5% | 15.7% |
| Forward P/E | 11.9x | 10.4x | 11.6x | 4.8x |
| Total Debt | $43M | $70M | $2M | $179M |
| Cash & Equiv. | $161M | $25M | $8M | $105M |
FXNC vs MNSB vs NKSH vs CARE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| First National Corp… (FXNC) | 100 | 210.5 | +110.5% |
| MainStreet Bancshar… (MNSB) | 100 | 177.1 | +77.1% |
| National Bankshares… (NKSH) | 100 | 121.6 | +21.6% |
| Carter Bankshares, … (CARE) | 100 | 372.8 | +272.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FXNC vs MNSB vs NKSH vs CARE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FXNC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.68, yield 2.2%
- Rev growth 27.1%, EPS growth 96.0%
- 241.1% 10Y total return vs CARE's 114.0%
- NIM 3.6% vs NKSH's 2.5%
MNSB is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs FXNC's 0.5%
NKSH is the clearest fit if your priority is defensive.
- Beta 0.73, yield 4.0%, current ratio 1203.84x
CARE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
- Beta 0.56 vs NKSH's 0.73
- +66.5% vs MNSB's +26.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs MNSB's -1.4% | |
| Value | PEG 7.95 vs 144.52 | |
| Quality / Margins | Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs NKSH's 0.73 | |
| Dividends | 2.2% yield, 11-year raise streak, vs NKSH's 4.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +66.5% vs MNSB's +26.6% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs FXNC's 0.5% |
FXNC vs MNSB vs NKSH vs CARE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FXNC vs MNSB vs NKSH vs CARE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FXNC leads in 1 of 6 categories
NKSH leads 1 • CARE leads 1 • MNSB leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FXNC leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARE is the larger business by revenue, generating $255M annually — 3.0x NKSH's $85M. NKSH is the more profitable business, keeping 18.6% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $112M | $136M | $85M | $255M |
| EBITDAEarnings before interest/tax | $25M | $23M | $20M | $46M |
| Net IncomeAfter-tax profit | $18M | $16M | $16M | $31M |
| Free Cash FlowCash after capex | $21M | $13M | $17M | $30M |
| Gross MarginGross profit ÷ Revenue | +74.0% | +54.4% | +65.1% | +61.7% |
| Operating MarginEBIT ÷ Revenue | +19.6% | +14.0% | +22.5% | +15.7% |
| Net MarginNet income ÷ Revenue | +15.8% | +11.5% | +18.6% | +12.3% |
| FCF MarginFCF ÷ Revenue | +18.7% | +7.8% | +17.8% | +12.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +7.1% | +120.9% | +91.7% | +8.3% |
Valuation Metrics
Evenly matched — FXNC and MNSB each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 13.4x trailing earnings, MNSB trades at a 29% valuation discount to CARE's 18.8x P/E. Adjusting for growth (PEG ratio), FXNC offers better value at 9.55x vs NKSH's 144.52x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $253M | $176M | $239M | $583M |
| Enterprise ValueMkt cap + debt − cash | $134M | $221M | $232M | $657M |
| Trailing P/EPrice ÷ TTM EPS | 14.27x | 13.35x | 15.04x | 18.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.87x | 10.44x | 11.63x | 4.79x |
| PEG RatioP/E ÷ EPS growth rate | 9.55x | — | 144.52x | — |
| EV / EBITDAEnterprise value multiple | 6.13x | 11.57x | 12.11x | 16.41x |
| Price / SalesMarket cap ÷ Revenue | 2.25x | 1.30x | 2.80x | 2.29x |
| Price / BookPrice ÷ Book value/share | 1.35x | 0.82x | 1.29x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 12.03x | 16.56x | 15.74x | 18.34x |
Profitability & Efficiency
NKSH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
FXNC delivers a 10.0% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $7 for MNSB. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), NKSH scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.0% | +7.3% | +9.0% | +7.6% |
| ROA (TTM)Return on assets | +0.9% | +0.7% | +0.9% | +0.7% |
| ROICReturn on invested capital | +7.7% | +5.0% | +8.4% | +5.7% |
| ROCEReturn on capital employed | +9.9% | +0.9% | +1.9% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 8 | 8 |
| Debt / EquityFinancial leverage | 0.23x | 0.32x | 0.01x | 0.43x |
| Net DebtTotal debt minus cash | -$118M | $45M | -$6M | $73M |
| Cash & Equiv.Liquid assets | $161M | $25M | $8M | $105M |
| Total DebtShort + long-term debt | $43M | $70M | $2M | $179M |
| Interest CoverageEBIT ÷ Interest expense | 0.84x | 0.31x | 0.64x | 0.39x |
Total Returns (Dividends Reinvested)
Evenly matched — FXNC and CARE each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,976 today (with dividends reinvested), compared to $12,091 for MNSB. Over the past 12 months, CARE leads with a +66.5% total return vs MNSB's +26.6%. The 3-year compound annual growth rate (CAGR) favors FXNC at 28.2% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.6% | +19.3% | +13.5% | +35.5% |
| 1-Year ReturnPast 12 months | +45.5% | +26.6% | +49.1% | +66.5% |
| 3-Year ReturnCumulative with dividends | +110.8% | +21.4% | +54.1% | +95.7% |
| 5-Year ReturnCumulative with dividends | +69.2% | +20.9% | +33.7% | +89.8% |
| 10-Year ReturnCumulative with dividends | +241.1% | +126.8% | +50.5% | +114.0% |
| CAGR (3Y)Annualised 3-year return | +28.2% | +6.7% | +15.5% | +25.1% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NKSH's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 99.0% from its 52-week high vs MNSB's 93.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 0.64x | 0.73x | 0.56x |
| 52-Week HighHighest price in past year | $29.85 | $25.17 | $40.00 | $26.58 |
| 52-Week LowLowest price in past year | $18.31 | $17.86 | $24.74 | $15.40 |
| % of 52W HighCurrent price vs 52-week peak | +93.7% | +93.4% | +93.7% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 52.1 | 52.1 | 58.1 | 75.5 |
| Avg Volume (50D)Average daily shares traded | 80K | 53K | 50K | 278K |
Analyst Outlook
Evenly matched — FXNC and NKSH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FXNC as "Buy", MNSB as "Hold", NKSH as "Buy", CARE as "Buy". Consensus price targets imply 2.6% upside for CARE (target: $27) vs -24.9% for FXNC (target: $21). For income investors, NKSH offers the higher dividend yield at 4.03% vs FXNC's 2.19%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $21.00 | — | — | $27.00 |
| # AnalystsCovering analysts | 1 | 1 | 4 | 4 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | — | +4.0% | — |
| Dividend StreakConsecutive years of raises | 11 | 2 | 1 | 0 |
| Dividend / ShareAnnual DPS | $0.61 | — | $1.51 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | 0.0% | +3.4% |
FXNC leads in 1 of 6 categories (Income & Cash Flow). NKSH leads in 1 (Profitability & Efficiency). 3 tied.
FXNC vs MNSB vs NKSH vs CARE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FXNC or MNSB or NKSH or CARE a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). MainStreet Bancshares, Inc. (MNSB) offers the better valuation at 13. 4x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate First National Corporation (FXNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FXNC or MNSB or NKSH or CARE?
On trailing P/E, MainStreet Bancshares, Inc.
(MNSB) is the cheapest at 13. 4x versus Carter Bankshares, Inc. at 18. 8x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: First National Corporation wins at 7. 95x versus National Bankshares, Inc. 's 144. 52x.
03Which is the better long-term investment — FXNC or MNSB or NKSH or CARE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +89. 8%, compared to +20. 9% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FXNC returned +241. 1% versus NKSH's +50. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FXNC or MNSB or NKSH or CARE?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus National Bankshares, Inc. 's 0. 73β — meaning NKSH is approximately 31% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FXNC or MNSB or NKSH or CARE?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 32. 1% for Carter Bankshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FXNC or MNSB or NKSH or CARE?
National Bankshares, Inc.
(NKSH) is the more profitable company, earning 18. 6% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 18. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NKSH leads at 22. 5% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FXNC or MNSB or NKSH or CARE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, First National Corporation (FXNC) is the more undervalued stock at a PEG of 7. 95x versus National Bankshares, Inc. 's 144. 52x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 9x for First National Corporation — 7. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 2. 6% to $27. 00.
08Which pays a better dividend — FXNC or MNSB or NKSH or CARE?
In this comparison, NKSH (4.
0% yield), FXNC (2. 2% yield) pay a dividend. MNSB, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is FXNC or MNSB or NKSH or CARE better for a retirement portfolio?
For long-horizon retirement investors, First National Corporation (FXNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
68), 2. 2% yield, +241. 1% 10Y return). Both have compounded well over 10 years (FXNC: +241. 1%, MNSB: +126. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FXNC and MNSB and NKSH and CARE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FXNC is a small-cap high-growth stock; MNSB is a small-cap deep-value stock; NKSH is a small-cap deep-value stock; CARE is a small-cap quality compounder stock. FXNC, NKSH pay a dividend while MNSB, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.